| |
 
   Powered by SearchMedica
SearchMedica recommended medical sites    Search Psychiatric Times    Prioritize Results by Publication Date

BPRS (Brief Psychiatric Rating Scale)

Persons having or suspected of having schizophrenia or other psychotic disorder manifest the disorder in multiple ways. The BPRS assesses the level of 18 symptom constructs such as hostility, suspiciousness, hallucination, and grandiosity. It is particularly useful in gauging the efficacy of treatment in patients who have moderate to severe psychoses.
It is based on the clinician's interview with the patient and observations of the patient's behavior over the previous 2-3 days. The patient's family can also provide the behavior report.
The rater enters a number for each symptom construct that ranges from 1 (not present) to 7 (extremely severe). The time necessary to complete the interview and scoring can be as little as 20-30 minutes.
   
 
More About Schizophrenia and the BPRS
Lilly Off-Label Promotion

Eli Lilly and Company pleaded guilty on January 30 to one misdemeanor violation of misbranding Zyprexa (olanzapine) by promoting it for dementia. However, a question raised by bloggers and others remains: did the drug benefit the elderly despite... More »

New Findings in Early-Onset Schizophrenia
Recently, a number of studies have examined the characteristics of early-onset schizophrenia spectrum disorders and medication treatment for youths with schizophrenia. More »
Complementary Therapies for Schizophrenia: Expanding the Clinician’s Toolbox
Given the burdens of living with schizophrenia, and the increasing focus on patients' quality of life, it’s no wonder clinicians are seeking other treatment options for the disorder. Here, a discussion of the most promising nonconventional therapies... More »
Antipsychotics in the Treatment of Comorbid Anxiety in Bipolar Disorder
The comorbidity of anxiety disorders with bipolar disorder is a rule, not an exception, with a negative impact on both course and treatment outcome. So far, there are no guidelines or consensus for the treatment of this comorbidity. More »
APA: Investigational Drug Treats Schizophrenia with Good Metabolic Profile
SAN DIEGO -- Bifeprunox, an investigational atypical antipsychotic agent, was significantly better than placebo at preventing deterioration of schizophrenia over six months and had a good metabolic profile. More »
Showing 6 - 10 of 27 results.
Jay M. Pomerantz, MD
Assistant Clinical Professor of Psychiatry
Harvard Medical School, Boston

A large number of psychiatric tests, scales, and forms have been created over the years to help in diagnosing mental illness and assisting in treatment and follow-up. This Web-based service offers copies of some of the most popular and useful instruments. The hope is that healthcare professionals—whether in specialty practices, primary-care settings, or emergency services—will find this format convenient and useful, allowing them to find the right instrument quickly, print it out for immediate use with patients, and add the findings to their records. Since most of the tools are designed for repeated use over time, they will provide not only a longitudinal view but also document the medical record.

In addition to the forms themselves, you will find instructions on how to administer and score the scales as well as related articles and links to other useful guidance. When appropriate, we will supply video resources for additional insights.

These scales have demonstrated high levels of accuracy and validity and the results can give important clues to possible mental disorders that warrant follow up. However, please remember that they depend on the skills of the clinicians administering them and the accuracy of the information provided by the patients.